CoChat
Sign Up
Cited by 217Immune Response and InflammationInflammatory Bowel DiseasePsoriasis: Treatment and Pathogenesis

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

A Synthetic TLR4 Antagonist Has Anti-Inflammatory Effects in Two Murine Models of Inflammatory Bowel Disease

Fort, Madeline M, Mozaffarian, Afsaneh, Stöver, Axel G, Correia, Jean da Silva, Johnson, David A, Crane, R Thomas, Ulevitch, Richard J, Persing, David H, Bielefeldt-Ohmann, Helle, Probst, Peter, Jeffery, Eric, Fling, Steven P, Hershberg, Robert M·2005·The Journal of Immunology
DOI 10.4049/jimmunol.174.10.6416
Open this paper in CoChat — free account

Abstract

Current evidence indicates that the chronic inflammation observed in the intestines of patients with inflammatory bowel disease is due to an aberrant immune response to enteric flora. We have developed a lipid A-mimetic, CRX-526, which has antagonistic activity for TLR4 and can block the interaction of LPS with the immune system. CRX-526 can prevent the expression of proinflammatory genes stimulated by LPS in vitro. This antagonist activity of CRX-526 is directly related to its structure, particularly secondary fatty acyl chain length. In vivo, CRX-526 treatment blocks the ability of LPS to induce TNF-alpha release. Importantly, treatment with CRX-526 inhibits the development of moderate-to-severe disease in two mouse models of colonic inflammation: the dextran sodium sulfate model and multidrug resistance gene 1a-deficient mice. By blocking the interaction between enteric bacteria and the innate immune system, CRX-526 may be an effective therapeutic molecule for inflammatory bowel disease.

Overview

Integrity signals

Registry

Crossref · 10.4049/jimmunol.174.10.6416

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 38

  1. 2000, Gastroenterology, S68
  2. 2002, Gastroenterology, 1592
  3. 1995, Clin. Exp. Immunol., 448
  4. 1997, Res. Immunol., 589
  5. 2001, Immunity, 5
  6. 2001, Nature, 603
  7. 2001, Nature, 599
  8. 2001, Gut, 609
  9. 2002, Annu. Rev. Immunol., 495
  10. 2002, Annu. Rev. Immunol., 197
  11. 2003, Annu. Rev. Immunol., 335
  12. 2003, Curr. Opin. Immunol., 396
  13. 2000, Proc. Natl. Acad. Sci. USA, 2163
  14. 2002, J. Biol. Chem., 1845
  15. 2003, J. Exp. Med., 1035
  16. 2001, Nat. Immunol., 675
  17. 2002, Curr. Opin. Immunol., 380
  18. 2003, Crit. Rev. Immunol., 15
  19. 1999, Bioorg. Med. Chem. Lett., 2273
  20. 2002, Trends Microbiol., S32
  21. 1992, Infect. Immun., 2694
  22. 2003, J. Biol. Chem., 4440
  23. 1997, Eur. J. Immunol., 2634
  24. 1993, Lab. Invest., 238
  25. 2002, Am. J. Pathol., 739
  26. 1996, APMIS, 823
  27. 1998, J. Immunol., 5733
  28. 2000, Int. Rev. Immunol., 63
  29. 1999, Immunity, 39
  30. 2003, J. Clin. Invest., 1297
  31. 2004, Cell, 229
  32. 2001, J. Immunol., 1609
  33. 1999, Br. J. Pharmacol., 853
  34. 2001, J. Immunol., 4074
  35. 2001, J. Immunol., 2651
  36. 2003, J. Exp. Med., 1225
  37. 2000, Infect. Immun., 7010
  38. 2002, Gastroenterology, 1987

Cited by

Sorted by citations

Items 201–217 of 217

Related

See all

Metadata

Authors
Fort, M. M., Mozaffarian, A., Stöver, A. G., Correia, J. D. S., Johnson, D. A., Crane, R. T., Ulevitch, R. J., Persing, D. H., Bielefeldt-Ohmann, H., Probst, P., Jeffery, E., Fling, S. P., & Hershberg, R. M.
Affiliations
  • Scripps Research Institute (US)
  • Corixa Corporation , Seattle, WA 98101
  • Washington National Primate Research Center, University of Washington , Seattle, WA 98195
ORCID
Venue
The Journal of Immunology
Publisher
Oxford University Press (OUP)
Published
2005-05
Volume
174
Issue
10
Pages
6416-6423
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
DOI
10.4049/jimmunol.174.10.6416
OpenAlex
W1906569767
Cited by
216
References
38
Citations by year
2026: 5 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 13 · 2021: 8 · 2020: 8 · 2019: 8 · 2018: 8 · 2017: 9 · 2016: 5 · 2015: 5 · 2014: 12 · 2013: 15 · 2012: 10
FWCI
6.64
Type
journal article
Language
en
Open access
closed
Licence
academic.oup.com/pages/standard-publication-reuse-rights (vor)
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords
TLR4 antagonist, inflammatory bowel disease, lipopolysaccharide, TNF-α, DSS-induced colitis, innate immunity, enteric bacteria, anti-inflammatory therapy, acyl chain length
MeSH terms
Adjuvants, Immunologic, Animals, Anti-Inflammatory Agents, Non-Steroidal, Caproates, Cells, Cultured, Colitis, Disease Models, Animal, Female, Glucosamine, HeLa Cells, Humans, Lipid A, Lipopolysaccharides, Mice, Inbred BALB C, Mice, Inbred C3H, Monocytes, Receptors, Immunologic, Tumor Necrosis Factor-alpha, Inflammatory Bowel Diseases, Dextran Sulfate, Mice, Knockout, ATP Binding Cassette Transporter, Subfamily B, Member 1, Toll-Like Receptor 4, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review